Kritoma

Discovery

Explore Topics Papers

Docs Terms Privacy

Search Kritoma

Recent searches

Searches you run from this bar will appear here.

Research opportunities

Identify missing evidence, datasets, methods, validation, and translational openings.

Filter

Gap type

Focus on the kind of missing evidence or opportunity.

Evidence status

Priority

Activity

Clear

Search query

Showing 1-12 of total 25 public research gaps.

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around rOR does not prove causation in liraglutide

Impact

65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved large data volumes pose computational challenges in spatial transcriptomics

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around retrospective nature of the study in plasma Aβ

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around nAFLD is often asymptomatic, delaying diagnosis in ctDNA

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around nAFLD is often asymptomatic, delaying diagnosis in ctDNA

Impact65%

Coverage60%

Dataset GapEvidence coverage: StrongImpact priority: Medium

Insufficient validation evidence for small patient cohort (16 patients) in biomaterials

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around study focused on post-mortem midbrain tissue in cytokines

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around ethical roadblocks in healthcare

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around tumorigenicity assessment was performed in immunocompromised mice (NOD/SCID) in bioreactors

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around tumorigenicity assessment was performed in immunocompromised mice (NOD/SCID) in bioreactors

Impact65%

Coverage60%

Evidence GapEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around antigen escape in CAR-T therapy

Impact65%

Coverage60%

ClinicalEvidence coverage: StrongImpact priority: Medium

Unresolved evidence gap around single patient case study in immunosuppression

Impact65%

Coverage60%

Page 1 of 3Showing 1-12 of total 25 gaps.

12 3